Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are scheduled to receive treatment with the WATCHMAN FLX™ Pro device, which is used to close off a small pouch in the heart.
- You have a type of irregular heartbeat called atrial fibrillation that is not caused by a problem with your heart valve, and your doctor has recommended this device for you.
- You, or your legal representative, are willing and able to give your informed consent to take part.
- You are able and willing to come back for all required follow-up appointments and check-ups.
- You are 18 years of age or older, or you meet the legal age requirement to give consent in your area.
Who may not be able to join:
- You have been told by a doctor that your life expectancy is less than 12 months.
- You are currently taking part in another clinical study or research trial (though participation in certain government-required registries or observation-only registries may be acceptable — confirm with trial site).
- You have a blood clot inside your heart.
- You already have a device in your heart that was used to repair or close a hole between the heart's chambers.
- The shape or size of the relevant part of your heart is not suitable for the closure device (confirm with trial site).
- You have a known allergy or medical reason that prevents you from using this device, based on the manufacturer's guidelines.
- You are pregnant, trying to become pregnant, or could become pregnant during the study period.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marek Grygier, Prof. MD, PHD, Uniwersytecki Szpital Kliniczny w Poznaniu
Phone: +491707828594
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with a safety event treated with the WATCHMAN FLX Pro; Number of participants with a safety event treated with the VersaCross Connect™ LAAC Access Solution; Number of participants with a successful VersaCross Connect™ LAAC Access Solution treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.